Dipna Pharmachem Limited (BOM:543594)
4.220
-0.170 (-3.87%)
At close: Nov 16, 2026
Dipna Pharmachem Revenue
Dipna Pharmachem had revenue of 203.30M INR in the quarter ending June 30, 2026, with 18.57% growth. This brings the company's total for the last twelve months to 1.31B, up 33.44% year-over-year. In the fiscal year ending March 31, 2026, Dipna Pharmachem had annual revenue of 1.29B with 3.34% growth. That makes Dipna Pharmachem the 35,812th largest company in the world by revenue and 3,007th in India.
Revenue (ttm)
1.31B
Revenue Growth
+33.44%
P/S Ratio
0.09
Revenue / Employee
n/a
Employees
13
Market Cap
110.94M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 1.29B | 41.66M | 3.34% |
| Mar 31, 2025 | 1.25B | -394.20M | -23.99% |
| Mar 31, 2024 | 1.64B | 644.10M | 64.46% |
| Mar 31, 2023 | 999.27M | 271.72M | 37.35% |
| Mar 31, 2022 | 727.55M | 417.56M | 134.70% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Centuple Global | 5.62B |
| Medico Intercontinental | 864.77M |
| Medistep Healthcare | 731.36M |
| Zenlabs Ethica | 485.60M |
| Goldline Pharmaceutical | 311.98M |
| Muller & Phipps (India) | 60.37M |
| Dhruv Wellness | 2.17M |
| Priya | 10.00K |